Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C182 - The New Era of Brain Health Across the Lifespan: How Science and Public Policy Can Improve Neurologic Outcomes for All

Wednesday 04/17/24
03:30 PM - 05:30 PM MDT Add To Calendar
Colorado Convention Center | 601
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Joel Salinas, MD, MBA, MSc, FAAN
General Neurology
Participants should become familiar with emerging evidence-based practice for timely and appropriate intervention to reduce risks and enhance protective factors for brain health conditions; learn how to consider development and implementation of interventions and systems-based practice to improve quality of life for those affected by brain health conditions appropriate to each life epoch; and, understand approaches to collaborate across disciplines, organizations, and initiatives to best coordinate research, education, and policy efforts to advance brain health.
2.00 CME credits
Advanced Practice Provider, Brain Health
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Program Materials

Event Timeline
03:30 PM - 03:50 PM MDT Speaker Brain Health: Yesterday, Today, and Tomorrow
Joel Salinas, MD, MBA, MSc, FAAN
03:50 PM - 04:15 PM MDT Speaker Brain Health in Early Life: The Strongest Start
Ann H. Tilton, MD, FAAN
04:15 PM - 04:40 PM MDT Speaker Brain Health in Mid Life: Prevent & Optimize, Recover & Preserve
Behnam Sabayan, MD, PhD, MSPH
04:40 PM - 05:05 PM MDT Speaker Brain Health in Late Life: Shining in the Platinum Years
Daniel Jose Correa, MD, MSc, FAAN
05:05 PM - 05:30 PM MDT Speaker Turning Science into Policy: AAN Leading the Charge
Justin T. Jordan, MD, MPH, FAAN
Faculty Disclosures
Joel Salinas, MD, MBA, MSc, FAAN Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health.
Justin T. Jordan, MD, MPH, FAAN Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Dietitians on Demand. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Harborlight Montesorri. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navio Theragnostics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CEC Oncology. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Texas Health Resources. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Children's Tumor Foundation. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BCD Meetings. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michigan State University. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for potential consultant role that was aborted with Magnet Biomedicine. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with Neurofibromatosis Northeast that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with ABA Academy that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a chair, scientific advisory board and board member with Neurofibromatosis Network that is relevant to AAN interests or activities.
Ann H. Tilton, MD, FAAN Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for allergan. Dr. Tilton has received personal compensation in the range of $0-$499 for serving as a Consultant for Medlink. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Tilton has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keane law firm - Defense.
Behnam Sabayan, MD, PhD, MSPH Dr. Sabayan has nothing to disclose.
Daniel Jose Correa, MD, MSc, FAAN Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Correa has stock in Aidin Inc. Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.